These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29214639)

  • 1. Cannabinoids for epilepsy: What do we know and where do we go?
    Brodie MJ; Ben-Menachem E
    Epilepsia; 2018 Feb; 59(2):291-296. PubMed ID: 29214639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.
    Devinsky O; Cilio MR; Cross H; Fernandez-Ruiz J; French J; Hill C; Katz R; Di Marzo V; Jutras-Aswad D; Notcutt WG; Martinez-Orgado J; Robson PJ; Rohrback BG; Thiele E; Whalley B; Friedman D
    Epilepsia; 2014 Jun; 55(6):791-802. PubMed ID: 24854329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of six new antiseizure medications for adjunctive treatment of focal epilepsy and epileptic syndrome: A systematic review and network meta-analysis.
    Tong J; Ji T; Liu T; Liu J; Chen Y; Li Z; Lu N; Li Q
    Epilepsy Behav; 2024 Mar; 152():109653. PubMed ID: 38277848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CBD in the Treatment of Epilepsy.
    Borowicz-Reutt K; Czernia J; Krawczyk M
    Molecules; 2024 Apr; 29(9):. PubMed ID: 38731471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabidiol Interactions with Medications, Illicit Substances, and Alcohol: a Comprehensive Review.
    Balachandran P; Elsohly M; Hill KP
    J Gen Intern Med; 2021 Jul; 36(7):2074-2084. PubMed ID: 33515191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in pharmacotherapy for epilepsy.
    Pong AW; Xu KJ; Klein P
    Curr Opin Neurol; 2023 Apr; 36(2):77-85. PubMed ID: 36762638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid treatments in epilepsy and seizure disorders.
    Devinsky O; Jones NA; Cunningham MO; Jayasekera BAP; Devore S; Whalley BJ
    Physiol Rev; 2024 Apr; 104(2):591-649. PubMed ID: 37882730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoids and Epilepsy.
    Rosenberg EC; Tsien RW; Whalley BJ; Devinsky O
    Neurotherapeutics; 2015 Oct; 12(4):747-68. PubMed ID: 26282273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New and emerging pharmacologic treatments for developmental and epileptic encephalopathies.
    Vasquez A; Buraniqi E; Wirrell EC
    Curr Opin Neurol; 2022 Apr; 35(2):145-154. PubMed ID: 35102126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New GABA-Targeting Therapies for the Treatment of Seizures and Epilepsy: II. Treatments in Clinical Development.
    Perucca E; White HS; Bialer M
    CNS Drugs; 2023 Sep; 37(9):781-795. PubMed ID: 37603261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of medical cannabinoids in children: a systematic review and meta-analysis.
    Treves N; Mor N; Allegaert K; Bassalov H; Berkovitch M; Stolar OE; Matok I
    Sci Rep; 2021 Dec; 11(1):23462. PubMed ID: 34873203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neural Stem Cells and Cannabinoids in the Spotlight as Potential Therapy for Epilepsy.
    Lourenço DM; Ribeiro-Rodrigues L; Sebastião AM; Diógenes MJ; Xapelli S
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33022963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new mechanism for cannabidiol in regulating the one-carbon cycle and methionine levels in Dictyostelium and in mammalian epilepsy models.
    Perry CJ; Finch P; Müller-Taubenberger A; Leung KY; Warren EC; Damstra-Oddy J; Sharma D; Patra PH; Glyn S; Boberska J; Stewart B; Baldwin A; Piscitelli F; Harvey RJ; Harwood A; Thompson C; Claus SP; Greene NDE; McNeish AJ; Williams CM; Whalley BJ; Williams RSB
    Br J Pharmacol; 2020 Feb; 177(4):912-928. PubMed ID: 31693171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human cannabinoid pharmacokinetics.
    Huestis MA
    Chem Biodivers; 2007 Aug; 4(8):1770-804. PubMed ID: 17712819
    [No Abstract]   [Full Text] [Related]  

  • 15. Slim evidence for cannabinoids for epilepsy.
    Miller JW
    Epilepsy Curr; 2013 Mar; 13(2):81-2. PubMed ID: 23646011
    [No Abstract]   [Full Text] [Related]  

  • 16. Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last?
    Perucca E
    J Epilepsy Res; 2017 Dec; 7(2):61-76. PubMed ID: 29344464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial.
    Thiele EA; Marsh ED; French JA; Mazurkiewicz-Beldzinska M; Benbadis SR; Joshi C; Lyons PD; Taylor A; Roberts C; Sommerville K;
    Lancet; 2018 Mar; 391(10125):1085-1096. PubMed ID: 29395273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for cannabis and cannabinoids for epilepsy: a systematic review of controlled and observational evidence.
    Stockings E; Zagic D; Campbell G; Weier M; Hall WD; Nielsen S; Herkes GK; Farrell M; Degenhardt L
    J Neurol Neurosurg Psychiatry; 2018 Jul; 89(7):741-753. PubMed ID: 29511052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigational cannabinoids in seizure disorders, what have we learned thus far?
    Ružić Zečević D; Folić M; Tantoush Z; Radovanović M; Babić G; Janković SM
    Expert Opin Investig Drugs; 2018 Jun; 27(6):535-541. PubMed ID: 29842819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticonvulsant Effects of Cannabidiol in Dravet Syndrome.
    Koubeissi M
    Epilepsy Curr; 2017; 17(5):281-282. PubMed ID: 29225539
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.